ALS Phase 1 Study NP001 Report for Patients Like You

What is ALS Phase 1 Study NP001?

An example of ALS Phase 1 Study NP001

NCT01091142 is a completed single-ascending-dose safety and tolerability study of NP001 in subjects with Amyotrophic Lateral Sclerosis (ALS). Other study name is NP001 Single Dose - ALS.

Reported Purpose & Perceived Effectiveness

Reasons and Perceived effectiveness
			Perceived Effectiveness
Purpose	# of patients	# of patients with evaluations	Major	Moderate	Slight	None	Can’t tell
ALS (Amyotrophic Lateral Sclerosis)	1	0

See 1 patient currently using ALS Phase 1 Study NP001

Mouse over the table for more information

Reported Schedules

	3 other monthly	5 other monthly
	1	1

Reported Stop Reasons

Why Patients Stopped Using ALS Phase 1 Study NP001 (multiple reasons could be selected)
Reason	# Patients	Percentage of patients
Course of treatment ended	1

See all 1 patient who’ve stopped using ALS Phase 1 Study NP001

Reported Duration See details about how long patients take this treatment ▼ Reported Duration Hide details ▲

Currently Using ALS Phase 1 Study NP001

A bar graph

0-1 month	1-3 months	3-6 months	6 months-1year	1-2 years	2 years or more
0	0	0	0	0	1